Allena Pharmaceuticals to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference

Rhea-AI Summary

Allena Pharmaceuticals (NASDAQ: ALNA) announced that President and CEO Louis Brenner will present a corporate overview at the 2020 Wedbush PacGrow Healthcare Virtual Conference on August 11, 2020, at 8:35 a.m. ET. A live audio webcast will be accessible in the Investors section of the company’s website, with a replay available for 30 days after the event. Allena specializes in developing oral enzyme therapeutics for rare metabolic and kidney disorders, focusing on hyperoxaluria treatment with its lead product candidate, reloxaliase.

NEWTON, Mass., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today announced that Louis Brenner, M.D., Allena’s President and Chief Executive Officer, will present a corporate overview at the 2020 Wedbush PacGrow Healthcare Virtual Conference on Tuesday, August 11, 2020, at 8:35 a.m. ET.  

A live audio webcast of the presentation will be available under “Events and Presentations” in the Investors section of the Company’s website at www.allenapharma.com. A replay of the webcast will be available on the Allena website for 30 days following the presentation.

About Allena Pharmaceuticals
Allena Pharmaceuticals, Inc. is a late-stage biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders. Allena’s lead product candidate, reloxaliase, is a first-in-class, oral enzyme therapeutic for the treatment of hyperoxaluria, a metabolic disorder characterized by markedly elevated urinary oxalate levels and commonly associated with kidney stones, chronic kidney disease and other serious kidney disorders.

Investor Contact
Hannah Deresiewicz
Stern Investor Relations, Inc.
212-362-1200
hannah.deresiewicz@sternir.com

Media Contact
Adam Daley
Berry & Company Public Relations
212-253-8881
adaley@berrypr.com

FAQ

When will Allena Pharmaceuticals present at the Wedbush PacGrow Healthcare Virtual Conference?

Allena Pharmaceuticals will present on August 11, 2020, at 8:35 a.m. ET.

How can I listen to Allena Pharmaceuticals' presentation?

The presentation can be accessed via a live audio webcast in the Investors section of Allena's website.

What is Allena Pharmaceuticals' lead product candidate?

Allena's lead product candidate is reloxaliase, aimed at treating hyperoxaluria.

What is hyperoxaluria?

Hyperoxaluria is a metabolic disorder characterized by elevated urinary oxalate levels, often associated with kidney stones and chronic kidney disease.

Where can I find the replay of Allena Pharmaceuticals' conference presentation?

A replay of the presentation will be available on Allena's website for 30 days following the event.